GENOMICS AND THERAPY (Q2023742): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): DEVELOP AN INNOVATIVE APPROACH TO TREATMENT OF RARE CANCER CANCER (HODGKIN’S LYMPHOMA, HODGKIN’S LYMPHOMA, SKIN CARCINOMA, MSI CANCER, CANCER OF KIDNEY CANCER, KIDNEY CANCER, THYROID CANCER, DEFICIENCY OF THE PIERUATE DEHYDROGENASE, MEDIOR1) CHARACTERISATION OF CELL MODELS AND BIOLOGICAL SAMPLES USING A GENOMIC APPROACH BASED ON THE PHENOTYPE OF RARE CANCER MODELS OF RARE CANCERS CAPABLE OF OBTAINING ESSENTIAL INFORMATION ABOUT THE GENOME, THE E...) |
||
Property / summary | |||
DEVELOP AN INNOVATIVE APPROACH TO TREATMENT OF RARE CANCER CANCER (HODGKIN’S LYMPHOMA, HODGKIN’S LYMPHOMA, SKIN CARCINOMA, MSI CANCER, CANCER OF KIDNEY CANCER, KIDNEY CANCER, THYROID CANCER, DEFICIENCY OF THE PIERUATE DEHYDROGENASE, MEDIOR1) CHARACTERISATION OF CELL MODELS AND BIOLOGICAL SAMPLES USING A GENOMIC APPROACH BASED ON THE PHENOTYPE OF RARE CANCER MODELS OF RARE CANCERS CAPABLE OF OBTAINING ESSENTIAL INFORMATION ABOUT THE GENOME, THE EXOMA, THE TRANSCRIPTIONAL STATE, THE TRANSCRIPTIONAL STATE OF CANCER, AND THE INTEGRATION OF THE DIFFERENT SEQUENCING TECHNIQUES, RITINPUT (English) | |||
Property / summary: DEVELOP AN INNOVATIVE APPROACH TO TREATMENT OF RARE CANCER CANCER (HODGKIN’S LYMPHOMA, HODGKIN’S LYMPHOMA, SKIN CARCINOMA, MSI CANCER, CANCER OF KIDNEY CANCER, KIDNEY CANCER, THYROID CANCER, DEFICIENCY OF THE PIERUATE DEHYDROGENASE, MEDIOR1) CHARACTERISATION OF CELL MODELS AND BIOLOGICAL SAMPLES USING A GENOMIC APPROACH BASED ON THE PHENOTYPE OF RARE CANCER MODELS OF RARE CANCERS CAPABLE OF OBTAINING ESSENTIAL INFORMATION ABOUT THE GENOME, THE EXOMA, THE TRANSCRIPTIONAL STATE, THE TRANSCRIPTIONAL STATE OF CANCER, AND THE INTEGRATION OF THE DIFFERENT SEQUENCING TECHNIQUES, RITINPUT (English) / rank | |||
Normal rank |
Revision as of 09:12, 23 March 2020
Project in Italy financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | GENOMICS AND THERAPY |
Project in Italy financed by DG Regio |
Statements
6,109,500.0 Euro
0 references
8,146,000.0 Euro
0 references
75.0 percent
0 references
1 January 2018
0 references
31 December 2020
0 references
ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE SENATORE G. PASCALE
0 references
FONDAZIONE TELETHON
0 references
TAKIS SRL
0 references
NOUSCOM SRL UNIPERSONALE
0 references
REGIONE CAMPANIA
0 references
DOMPE' FARMACEUTICI SPA
0 references
SVILUPPARE UN APPROCCIO INNOVATIVO PER LA CURA DELLE MALATTIE ONCOLOGICHE RARE (CARCINOMA A CELLULE DI MERKEL, LINFOMA DI HODGKIN, LINFOMI CUTANEI, MELANOMA UVEALE, TUMORE MSI, CARCINOMA DI CELLULE RENALI DA TRASLOCAZIONE TFE, CANCRO ALLA TIROIDE, DEFICIT DEL COMPLESSO PIRUVATO DEIDROGENASI, MUCOPOLISACCARIDOSI DI TIPO VI.), FINALZIZATO A DEFINIRE L'ORIGINE, L'EVOLUZIONE E LA DIFFUSIONE DEL PROCESSO CANCEROSO, MEDIANTE1) CARATTERIZZAZIONE DEI MODELLI CELLULARI E DEI CAMPIONI BIOLOGICI MEDIANTE UN APPROCCIO GENOMICO BASATO SULLA FENOTIPIZZAZIONE OLISTICA DI MODELLI CELLULARI DI TUMORI RARI IN GRADO DI OTTENERE INFORMAZIONI ESSENZIALI SUL GENOMA, SULL'ESOMA, SULLO STATO TRASCRIZIONALE E EPIGENETICO DEL DNA (INCLUSI I PROFILI DI METILAZIONE DEL DNA E L'ACCESSIBILITÃ DELLA CROMATINA).2) SVILUPPO DI TERAPIE SPECIFICHE UTILIZZANDO APPROCCI DI ULTIMA GENERAZIONE MENDIANTE MODELLI CELLULARIDI TUMORI RARI.ATTRAVERSO L'INTEGRAZIONE DELLE DIVERSE TECNICHE DI SEQUENZIAMENTO, SI RITINEE POSSIB (Italian)
0 references
DEVELOP AN INNOVATIVE APPROACH TO TREATMENT OF RARE CANCER CANCER (HODGKIN’S LYMPHOMA, HODGKIN’S LYMPHOMA, SKIN CARCINOMA, MSI CANCER, CANCER OF KIDNEY CANCER, KIDNEY CANCER, THYROID CANCER, DEFICIENCY OF THE PIERUATE DEHYDROGENASE, MEDIOR1) CHARACTERISATION OF CELL MODELS AND BIOLOGICAL SAMPLES USING A GENOMIC APPROACH BASED ON THE PHENOTYPE OF RARE CANCER MODELS OF RARE CANCERS CAPABLE OF OBTAINING ESSENTIAL INFORMATION ABOUT THE GENOME, THE EXOMA, THE TRANSCRIPTIONAL STATE, THE TRANSCRIPTIONAL STATE OF CANCER, AND THE INTEGRATION OF THE DIFFERENT SEQUENCING TECHNIQUES, RITINPUT (English)
0 references
Identifiers
B61C17000060007
0 references